A group of experts discussed the approval process for teclistamab use in patients with multiple myeloma.
ONCOLOGY® Companion, Volume 38, Supplement 1
An overview of NRG1 fusion–positive tumors was given by experts in the gastrointestinal and lung cancer space in a recent Frontline Forum.
Thomas Hutson, DO, PharmD, meets with his patient Cesar Fuentes to discuss his diagnosis and treatment for renal cell carcinoma.
Advertisement
Advertisement
Trending on CancerNetwork
1
PEG Hydrogel Reduces Rectal Radiation During Cervical Cancer Therapy
2
Early Detection, Education Are Key to Combat Rising Pancreatic Cancer Cases
3
Examining Developments in Safe Administration of Nuclear Agents
4
Sonrotoclax Earns FDA Priority Review in R/R Mantle Cell Lymphoma
5
